S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|CORRECTING and REPLACING -- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Impax Laboratories, Inc. of Class Action Lawsuit and Upcoming Deadline -- IPXL (2014/10/10)|
|Impax Laboratories to Present at the 2014 Credit Suisse Healthcare Conference on November 11|
|IPXL Shareholder Alert: Do You Own Stock in IPXL Educational Services?|
|Impax Pharmaceuticals Announce FDA Approval of RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules for the Treatment of Parkinson's disease|
|Impax Announces R&D Reorganization Designed to Yield Process Improvements and Efficiencies|
|Impax's Third Quarter 2014 Revenues Increased 19% to $158 Million|
|Impax Submits Marketing Authorization Application to EMA for IPX066 (Carbidopa-Levodopa) Extended-Release Capsules|
|Impax to Present at the 33rd Annual J.P. Morgan Healthcare Conference|
Click above to view more mutual fund data and stats for ipxl - Impax Laboratories Inc.